Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)

Name: Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
License: Public Domain

Candel Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non

non-squamous, non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 444864
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.